Distribution of company announcements to the professional platforms, finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems.
Okmetic Oyj (HEL:OKM1V) The board of directors of Okmetic Oyj has decided to convene an extraordinary general meeting on Thursday 6 November 2008 at 8.30 a.m. The meeting will be held in the Seutula conference room in Okmetic's head office at Piitie 2 in Koivuhaka, Vantaa, Finland.
The official notice of general meeting will be published in the Helsingin Sanomat newspaper on Wednesday 15 October 2008.
The agenda for the meeting will include:
1. Appointing a new member of the board of directors
Okmetic Oyj's shareholders Outokumpu Oyj and Accendo Capital, which together hold approximately 31.8 percent of the company's shares and the associated votes, have announced that they will be putting forward a proposal at the extraordinary general meeting for an additional member to be appointed to join the current five members of the company's board of directors and for the new member to be remunerated proportionally to the length of his term of office as per the decision of the annual general meeting of 3 April 2008.
The shareholders in question propose that the new member be Henri Österlund, M.Sc. (Economics and Business Administration), who has agreed to the appointment. Mr Österlund is the managing director of Accendo Capital Partners Oy, and he has held several positions within the capital market over several years.
2. The board of directors' authorisation to decide on repurchasing the company's own shares
The board of directors will be putting forward a proposal at the extraordinary general meeting for the company's board of directors to be authorised to decide on repurchasing the company's own shares as follows:
The aggregate number of shares repurchased on the basis of the authorisation cannot exceed 1,688,750 shares, which represents 10 percent of all the shares of the company. The company and its subsidiaries together cannot at any time own more than 10 percent of all of the company's registered shares.
Only unrestricted shareholders' equity can be used to repurchase the company's own shares under the authorisation. Own shares can be repurchased at a price determined by public trading on the day of repurchase or at another market-based price.
The board of directors can decide the method of repurchasing the company's own shares as well as the other terms and conditions. Derivatives, for example, can be used in the repurchase. Shares can be repurchased independently of the shareholders' proportional share holdings (directed repurchase). The board of directors proposes that the authorisation remain in force until the annual general meeting of spring 2010, however, until no later than 6 May 2010.
3. The board of directors' authorisation to decide on transferring rights to the company's own shares
The board of directors will be putting forward a proposal at the extraordinary general meeting for the company's board of directors to be authorised to decide on share issues for transferring rights to the company's own shares as follows: The aggregate number of rights transferred on the basis of the authorisation cannot exceed 1,688,750 shares, which represents 10 percent of all the shares of the company. The board of directors will be authorised to decide on all the terms and conditions of the share issues. The authorisation will be limited to transferring rights to the company's own shares as held by the company. The share issue can be carried out as a directed issue. The board of directors may also decide to cancel the repurchased shares. The authorisation will be effective until further notice, however, until no later than 30 June 2013. Moreover, the authorisation cannot override the authorisation granted at the annual general meeting of 3 April 2008 regarding share issues.
Participation at the extraordinary general meeting
All shareholders who have by no later than Monday 27 October 2008 been recorded as shareholders in the list of owners kept by the Nordic Central Securities Depository have the right to attend the meeting. Shareholders with nominee registration can take part in the meeting providing that they have no later than on Monday 27 October 2008 been temporarily added to the list of shareholders. Shareholders with nominee accounts held by custodian banks must contact their broker well in advance of the aforementioned date in order to take part in the meeting.
Registration
Shareholders who wish to attend the meeting should inform the head office of Okmetic Oyj thereof by Wednesday 29 October 2008 (at Piitie 2, Vantaa, room 5.1.31) during office hours from Monday to Friday between 8.00 a.m. and 4.00 p.m. Registration is also possible via email at shareholders@okmetic.com, by telephone on +358 9 5028 0406, or by post to Okmetic Oyj, Share Register, P.O. Box 44, FI-01301 Vantaa, Finland. In addition to their name, shareholders are asked to provide their personal identity code or business identity code. Registration by post requires that the letter arrive before the end of the registration period. Should the participant be a legal representative whom a shareholder has given the right to vote by proxy, this should be disclosed in connection with registration and the proxy statement should be left or supplied to the company's head office within the duration of the registration period.
Documents on display for public inspection
The aforementioned proposals of the board of directors, the company's most recent financial statements, annual report and auditor's report, as well as the interim reports produced after the end of the most recently concluded financial year (of which the report for the period of 1 January - 30 September 2008 will be published on 30 October 2008, and includes the board of directors' report on events that have taken place after the release of the interim report insofar as they significantly affect the company's position) will be available for the shareholders to inspect in room 5.1.31 of the company's head office at Piitie 2 in Koivuhaka, Vantaa from Thursday 30 October 2008 onwards. From the aforementioned date onwards, shareholders can ask the company to supply a copy of the aforementioned documents. The proposals of the board of directors will also be on display at the extraordinary general meeting and can be found online at http://www.okmetic.com/www/page/investors.
OMX Nordic Exchange Principal media www.okmetic.com
OKMETIC IN BRIEF
Take it higher
Okmetic is a technology company which supplies tailor-made silicon wafers for sensor and semiconductor industries and sells its technological expertise. Okmetic provides its customers with solutions that boost their competitiveness and profitability.
Okmetic's silicon wafers are part of a further processing chain that produces end products that improve human interaction and quality of life. Okmetic's products are based on high-tech expertise that generates added value for customers, innovative product development and efficient production process.
Okmetic has a global customer base and sales network, production plants in Finland and the US and contract manufacturers in Japan and China.
Okmetic's shares are listed on OMX Nordic Exchange under the code OKM1V. For more information on the company, please visit our website at www.okmetic.com.
